[1] NCD Risk Factor Collaboration. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants[J]. Lancet, 2024, 404(10467): 2077-2093. [2] THALS C, SHITYAKOV S, SALVADOR E, et al. Heart rate variability, microvascular dysfunction, and inflammation: exploring the potential of taVNS in managing heart failure in type 2 diabetes mellitus[J]. Biomolecules, 2025, 15(4): 499. [3] 陈盈欣, 胡欣, 李博, 等. 睡眠障碍对2型糖尿病的影响与治疗策略[J]. 中华糖尿病杂志, 2025, 17(3): 409-413. [4] 罗彦相, 张佳, 蔡青云, 等. 糖尿病心脏自主神经病变的研究进展[J]. 中国心血管杂志, 2025, 30(1): 16-21. [5] 陈昕露, 周艺铭, 韩雪, 等. 睡眠障碍与老年术后认知功能障碍的双向关联研究进展[J]. 实用老年医学, 2024, 38(5): 433-437. [6] ZOU N, ZHOU Q, ZHANG Y, et al. Transcutaneous auricular vagus nerve stimulation as a novel therapy connecting the central and peripheral systems: a review[J]. Int J Surg, 2024, 110(8): 4993-5006. [7] AHMED I, MUSTAFAOGLU R, ROSSI S, et al. Non-invasive brain stimulation techniques for the improvement of upper limb motor function and performance in activitiesof daily living after stroke: a systematic review and network meta-analysis[J]. Arch Phys Med Rehabil, 2023, 104(10): 1683-1697. [8] COSTA V, GIANLORENÇO A C, ANDRADE M F, et al. Transcutaneous vagus nerve stimulation effects on chronic pain: systematic review and meta-analysis[J]. Pain Rep, 2024, 9(5): e1171. [9] TAN C, QIAO M, MA Y, et al. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: a systematic review and meta-analysis of randomized controlled trials[J]. J Affect Disord, 2023, 337: 37-49. [10] 《中国老年型糖尿病防治临床指南》编写组. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中国糖尿病杂志, 2022, 30(1): 2-51. [11] ZHANG S, ZHAO Y, QIN Z, et al. Transcutaneous auricular vagus nerve stimulation for chronic insomnia disorder: a randomized clinical trial[J]. JAMA Netw Open, 2024, 7(12): e2451217. [12] 周航, 王丽琼, 屠建锋, 等. 针刺随机对照试验中盲法评价现状与方法学思考[J]. 中医杂志, 2024, 65(19): 1978-1982, 1987. [13] LI L, XU D, XU M, et al. Insomnia and its risk factors in patients with type 2 diabetes:a cross-sectional study[J]. Sleep Med, 2025, 131: 106484. [14] LIU C, CHEN S, ZHANG Y, et al. Transcutaneous auricular vagus nerve stimulation (taVNS) for insomnia disorder: a narrative review of effectiveness, mechanisms and recommendations for clinical practice[J]. Nat Sci Sleep, 2025, 17: 1327-1344. [15] MA C, ZHOU N, MA K, et al. Neural pathways from hypothalamic orexin neurons to the ventrolateral preoptic area mediate sleep impairments induced by conditioned fear[J]. Front Neurosci, 2023, 17:1122803. [16] ZHAO B, BI Y, CHEN Y, et al. Altered functional connectivity of the thalamus in patients with insomnia disorder after transcutaneous auricular vagus nerve stimulation therapy[J]. Front Neurol, 2023, 14: 1164869. [17] 陈兰英, 张旭, 肖志娟, 等. 尼麦角林联合经皮耳迷走神经电刺激治疗脑卒中患者认知功能障碍的疗效及其作用机制分析[J]. 川北医学院学报, 2025, 40(1): 85-88. [18] WANG J Y, ZHANG Y, CHEN Y, et al. Mechanisms underlying antidepressant effect of transcutaneous auricular vagus nerve stimulation on CUMS model rats based on hippocampal α7nAchR/NF-κB signal pathway[J]. J Neuroinflammation, 2021, 18(1): 291. |